nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—SIGMAR1—amyotrophic lateral sclerosis	0.661	1	CbGaD
Sertraline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.112	1	CbGbCtD
Sertraline—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0226	CcSEcCtD
Sertraline—Stridor—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0169	CcSEcCtD
Sertraline—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0148	CcSEcCtD
Sertraline—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0148	CcSEcCtD
Sertraline—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0148	CcSEcCtD
Sertraline—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0148	CcSEcCtD
Sertraline—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0145	CcSEcCtD
Sertraline—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00241	0.014	CcSEcCtD
Sertraline—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0137	CcSEcCtD
Sertraline—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00224	0.013	CcSEcCtD
Sertraline—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0118	CcSEcCtD
Sertraline—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0118	CcSEcCtD
Sertraline—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0114	CcSEcCtD
Sertraline—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0111	CcSEcCtD
Sertraline—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0109	CcSEcCtD
Sertraline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0109	CcSEcCtD
Sertraline—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0105	CcSEcCtD
Sertraline—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0105	CcSEcCtD
Sertraline—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0101	CcSEcCtD
Sertraline—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00174	0.0607	CbGeAlD
Sertraline—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00997	CcSEcCtD
Sertraline—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00972	CcSEcCtD
Sertraline—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00938	CcSEcCtD
Sertraline—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00928	CcSEcCtD
Sertraline—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00917	CcSEcCtD
Sertraline—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00917	CcSEcCtD
Sertraline—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00907	CcSEcCtD
Sertraline—MAOB—nerve—amyotrophic lateral sclerosis	0.00152	0.0529	CbGeAlD
Sertraline—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00869	CcSEcCtD
Sertraline—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00817	CcSEcCtD
Sertraline—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00141	0.049	CbGeAlD
Sertraline—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0081	CcSEcCtD
Sertraline—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00802	CcSEcCtD
Sertraline—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00787	CcSEcCtD
Sertraline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0078	CcSEcCtD
Sertraline—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00773	CcSEcCtD
Sertraline—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00773	CcSEcCtD
Sertraline—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00766	CcSEcCtD
Sertraline—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00766	CcSEcCtD
Sertraline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00759	CcSEcCtD
Sertraline—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.0013	0.0455	CbGeAlD
Sertraline—MAOA—nerve—amyotrophic lateral sclerosis	0.00129	0.0451	CbGeAlD
Sertraline—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00746	CcSEcCtD
Sertraline—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00739	CcSEcCtD
Sertraline—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00739	CcSEcCtD
Sertraline—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00733	CcSEcCtD
Sertraline—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00733	CcSEcCtD
Sertraline—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.0012	0.0417	CbGeAlD
Sertraline—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00666	CcSEcCtD
Sertraline—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00114	0.0396	CbGeAlD
Sertraline—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00651	CcSEcCtD
Sertraline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00642	CcSEcCtD
Sertraline—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00632	CcSEcCtD
Sertraline—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00628	CcSEcCtD
Sertraline—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00607	CcSEcCtD
Sertraline—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00603	CcSEcCtD
Sertraline—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00599	CcSEcCtD
Sertraline—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00595	CcSEcCtD
Sertraline—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00583	CcSEcCtD
Sertraline—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00583	CcSEcCtD
Sertraline—Cataract—Riluzole—amyotrophic lateral sclerosis	0.001	0.0058	CcSEcCtD
Sertraline—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00565	CcSEcCtD
Sertraline—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00562	CcSEcCtD
Sertraline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00562	CcSEcCtD
Sertraline—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00097	0.0338	CbGeAlD
Sertraline—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00552	CcSEcCtD
Sertraline—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00552	CcSEcCtD
Sertraline—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00552	CcSEcCtD
Sertraline—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00545	CcSEcCtD
Sertraline—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00545	CcSEcCtD
Sertraline—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000932	0.00539	CcSEcCtD
Sertraline—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00533	CcSEcCtD
Sertraline—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00533	CcSEcCtD
Sertraline—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00524	CcSEcCtD
Sertraline—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00518	CcSEcCtD
Sertraline—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00518	CcSEcCtD
Sertraline—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00507	CcSEcCtD
Sertraline—Coma—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00504	CcSEcCtD
Sertraline—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00499	CcSEcCtD
Sertraline—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00484	CcSEcCtD
Sertraline—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000828	0.00479	CcSEcCtD
Sertraline—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00474	CcSEcCtD
Sertraline—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000812	0.0047	CcSEcCtD
Sertraline—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000812	0.0047	CcSEcCtD
Sertraline—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00461	CcSEcCtD
Sertraline—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00461	CcSEcCtD
Sertraline—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00456	CcSEcCtD
Sertraline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00448	CcSEcCtD
Sertraline—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00446	CcSEcCtD
Sertraline—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.000748	0.0261	CbGeAlD
Sertraline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00432	CcSEcCtD
Sertraline—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00426	CcSEcCtD
Sertraline—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00426	CcSEcCtD
Sertraline—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000728	0.00421	CcSEcCtD
Sertraline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000718	0.00416	CcSEcCtD
Sertraline—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00414	CcSEcCtD
Sertraline—MAOB—embryo—amyotrophic lateral sclerosis	0.000711	0.0248	CbGeAlD
Sertraline—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00402	CcSEcCtD
Sertraline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00401	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00401	CcSEcCtD
Sertraline—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00401	CcSEcCtD
Sertraline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00397	CcSEcCtD
Sertraline—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.000685	0.0239	CbGeAlD
Sertraline—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000682	0.00394	CcSEcCtD
Sertraline—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000682	0.00394	CcSEcCtD
Sertraline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00391	CcSEcCtD
Sertraline—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00387	CcSEcCtD
Sertraline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000658	0.00381	CcSEcCtD
Sertraline—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000656	0.00379	CcSEcCtD
Sertraline—MAOB—brainstem—amyotrophic lateral sclerosis	0.000651	0.0227	CbGeAlD
Sertraline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00377	CcSEcCtD
Sertraline—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000644	0.00373	CcSEcCtD
Sertraline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00366	CcSEcCtD
Sertraline—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00362	CcSEcCtD
Sertraline—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00355	CcSEcCtD
Sertraline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00353	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00353	CcSEcCtD
Sertraline—MAOA—embryo—amyotrophic lateral sclerosis	0.000607	0.0211	CbGeAlD
Sertraline—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.000603	0.021	CbGeAlD
Sertraline—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000602	0.00349	CcSEcCtD
Sertraline—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000598	0.00346	CcSEcCtD
Sertraline—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00339	CcSEcCtD
Sertraline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000576	0.0201	CbGeAlD
Sertraline—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00333	CcSEcCtD
Sertraline—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000568	0.00329	CcSEcCtD
Sertraline—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00056	0.00324	CcSEcCtD
Sertraline—MAOA—brainstem—amyotrophic lateral sclerosis	0.000556	0.0194	CbGeAlD
Sertraline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000553	0.0032	CcSEcCtD
Sertraline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000551	0.00319	CcSEcCtD
Sertraline—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00316	CcSEcCtD
Sertraline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00315	CcSEcCtD
Sertraline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00313	CcSEcCtD
Sertraline—Depression—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00308	CcSEcCtD
Sertraline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000526	0.00304	CcSEcCtD
Sertraline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00303	CcSEcCtD
Sertraline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00303	CcSEcCtD
Sertraline—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00052	0.00301	CcSEcCtD
Sertraline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00052	0.00301	CcSEcCtD
Sertraline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000512	0.00296	CcSEcCtD
Sertraline—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000509	0.00294	CcSEcCtD
Sertraline—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00292	CcSEcCtD
Sertraline—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00291	CcSEcCtD
Sertraline—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000501	0.0029	CcSEcCtD
Sertraline—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00288	CcSEcCtD
Sertraline—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000488	0.00282	CcSEcCtD
Sertraline—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000481	0.00279	CcSEcCtD
Sertraline—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00278	CcSEcCtD
Sertraline—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00277	CcSEcCtD
Sertraline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00277	CcSEcCtD
Sertraline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000477	0.00276	CcSEcCtD
Sertraline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000477	0.00276	CcSEcCtD
Sertraline—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000475	0.00275	CcSEcCtD
Sertraline—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000475	0.0165	CbGeAlD
Sertraline—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000473	0.00274	CcSEcCtD
Sertraline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00273	CcSEcCtD
Sertraline—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00272	CcSEcCtD
Sertraline—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00272	CcSEcCtD
Sertraline—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.000465	0.0162	CbGeAlD
Sertraline—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000454	0.0158	CbGeAlD
Sertraline—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000453	0.00262	CcSEcCtD
Sertraline—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00259	CcSEcCtD
Sertraline—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000445	0.00257	CcSEcCtD
Sertraline—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000435	0.00251	CcSEcCtD
Sertraline—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000433	0.0025	CcSEcCtD
Sertraline—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000432	0.0025	CcSEcCtD
Sertraline—Chills—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00249	CcSEcCtD
Sertraline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000428	0.00248	CcSEcCtD
Sertraline—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.000426	0.0149	CbGeAlD
Sertraline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000423	0.00245	CcSEcCtD
Sertraline—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000423	0.0147	CbGeAlD
Sertraline—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000421	0.0147	CbGeAlD
Sertraline—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00243	CcSEcCtD
Sertraline—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000417	0.00241	CcSEcCtD
Sertraline—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00238	CcSEcCtD
Sertraline—Tension—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00237	CcSEcCtD
Sertraline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00236	CcSEcCtD
Sertraline—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000405	0.0141	CbGeAlD
Sertraline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00234	CcSEcCtD
Sertraline—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00233	CcSEcCtD
Sertraline—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00232	CcSEcCtD
Sertraline—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.000392	0.0137	CbGeAlD
Sertraline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00226	CcSEcCtD
Sertraline—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.000388	0.0135	CbGeAlD
Sertraline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00224	CcSEcCtD
Sertraline—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000385	0.00223	CcSEcCtD
Sertraline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000383	0.00222	CcSEcCtD
Sertraline—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000381	0.0022	CcSEcCtD
Sertraline—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.000377	0.0131	CbGeAlD
Sertraline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000376	0.00218	CcSEcCtD
Sertraline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00217	CcSEcCtD
Sertraline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00216	CcSEcCtD
Sertraline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00216	CcSEcCtD
Sertraline—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.000369	0.0128	CbGeAlD
Sertraline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00213	CcSEcCtD
Sertraline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00212	CcSEcCtD
Sertraline—Cough—Riluzole—amyotrophic lateral sclerosis	0.000364	0.00211	CcSEcCtD
Sertraline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000361	0.00209	CcSEcCtD
Sertraline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00208	CcSEcCtD
Sertraline—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000359	0.0125	CbGeAlD
Sertraline—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00205	CcSEcCtD
Sertraline—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00205	CcSEcCtD
Sertraline—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00205	CcSEcCtD
Sertraline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00205	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00204	CcSEcCtD
Sertraline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000351	0.00203	CcSEcCtD
Sertraline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00201	CcSEcCtD
Sertraline—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000346	0.012	CbGeAlD
Sertraline—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000346	0.012	CbGeAlD
Sertraline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00199	CcSEcCtD
Sertraline—MAOB—nervous system—amyotrophic lateral sclerosis	0.000341	0.0119	CbGeAlD
Sertraline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00197	CcSEcCtD
Sertraline—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00197	CcSEcCtD
Sertraline—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000336	0.0117	CbGeAlD
Sertraline—Shock—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00194	CcSEcCtD
Sertraline—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00193	CcSEcCtD
Sertraline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00193	CcSEcCtD
Sertraline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000332	0.00192	CcSEcCtD
Sertraline—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00191	CcSEcCtD
Sertraline—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00033	0.0115	CbGeAlD
Sertraline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000329	0.0019	CcSEcCtD
Sertraline—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000329	0.0115	CbGeAlD
Sertraline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00188	CcSEcCtD
Sertraline—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000321	0.0112	CbGeAlD
Sertraline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000318	0.00184	CcSEcCtD
Sertraline—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000316	0.011	CbGeAlD
Sertraline—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00179	CcSEcCtD
Sertraline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00178	CcSEcCtD
Sertraline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00177	CcSEcCtD
Sertraline—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000304	0.0106	CbGeAlD
Sertraline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000303	0.00176	CcSEcCtD
Sertraline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000303	0.00175	CcSEcCtD
Sertraline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00173	CcSEcCtD
Sertraline—SLC6A3—brain—amyotrophic lateral sclerosis	0.000299	0.0104	CbGeAlD
Sertraline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00171	CcSEcCtD
Sertraline—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000294	0.0017	CcSEcCtD
Sertraline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000293	0.0017	CcSEcCtD
Sertraline—MAOA—nervous system—amyotrophic lateral sclerosis	0.000291	0.0101	CbGeAlD
Sertraline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00168	CcSEcCtD
Sertraline—Pain—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00168	CcSEcCtD
Sertraline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00162	CcSEcCtD
Sertraline—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00028	0.00977	CbGeAlD
Sertraline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000278	0.00161	CcSEcCtD
Sertraline—SLC6A4—brain—amyotrophic lateral sclerosis	0.000274	0.00956	CbGeAlD
Sertraline—MAOA—cerebellum—amyotrophic lateral sclerosis	0.000274	0.00955	CbGeAlD
Sertraline—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000273	0.0095	CbGeAlD
Sertraline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00027	0.00156	CcSEcCtD
Sertraline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00156	CcSEcCtD
Sertraline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00156	CcSEcCtD
Sertraline—MAOB—brain—amyotrophic lateral sclerosis	0.000261	0.00909	CbGeAlD
Sertraline—ABCB1—embryo—amyotrophic lateral sclerosis	0.000259	0.00904	CbGeAlD
Sertraline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000251	0.00145	CcSEcCtD
Sertraline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000244	0.00141	CcSEcCtD
Sertraline—SLC6A2—brain—amyotrophic lateral sclerosis	0.000242	0.00842	CbGeAlD
Sertraline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000241	0.00139	CcSEcCtD
Sertraline—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000233	0.00812	CbGeAlD
Sertraline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000233	0.00135	CcSEcCtD
Sertraline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000225	0.0013	CcSEcCtD
Sertraline—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000224	0.00782	CbGeAlD
Sertraline—MAOA—brain—amyotrophic lateral sclerosis	0.000223	0.00776	CbGeAlD
Sertraline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000216	0.00125	CcSEcCtD
Sertraline—Rash—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00124	CcSEcCtD
Sertraline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000214	0.00124	CcSEcCtD
Sertraline—Headache—Riluzole—amyotrophic lateral sclerosis	0.000213	0.00123	CcSEcCtD
Sertraline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00117	CcSEcCtD
Sertraline—CYP2B6—brain—amyotrophic lateral sclerosis	0.000178	0.0062	CbGeAlD
Sertraline—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000176	0.00613	CbGeAlD
Sertraline—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000173	0.00603	CbGeAlD
Sertraline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000169	0.0059	CbGeAlD
Sertraline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000167	0.00581	CbGeAlD
Sertraline—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000166	0.00577	CbGeAlD
Sertraline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000163	0.00568	CbGeAlD
Sertraline—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000148	0.00515	CbGeAlD
Sertraline—CYP2D6—brain—amyotrophic lateral sclerosis	0.000132	0.00461	CbGeAlD
Sertraline—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000124	0.00434	CbGeAlD
Sertraline—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00012	0.00418	CbGeAlD
Sertraline—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000117	0.00408	CbGeAlD
Sertraline—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000104	0.00403	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000103	0.00399	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000102	0.00399	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000102	0.00399	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000102	0.00399	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.9e-05	0.00385	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	9.63e-05	0.00375	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	9.56e-05	0.00372	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	9.52e-05	0.00371	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	9.52e-05	0.00371	CbGpPWpGaD
Sertraline—ABCB1—brain—amyotrophic lateral sclerosis	9.52e-05	0.00332	CbGeAlD
Sertraline—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	9.5e-05	0.0037	CbGpPWpGaD
Sertraline—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	9.29e-05	0.00362	CbGpPWpGaD
Sertraline—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.24e-05	0.00359	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	9.23e-05	0.00359	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	9.13e-05	0.00355	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	9.08e-05	0.00353	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	8.89e-05	0.00346	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	8.72e-05	0.00339	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.7e-05	0.00338	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	8.64e-05	0.00336	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	8.58e-05	0.00334	CbGpPWpGaD
Sertraline—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	8.5e-05	0.00331	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	8.49e-05	0.0033	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	8.45e-05	0.00329	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	8.42e-05	0.00327	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.08e-05	0.00314	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	7.89e-05	0.00307	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	7.85e-05	0.00305	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	7.85e-05	0.00305	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	7.85e-05	0.00305	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	7.77e-05	0.00302	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	7.72e-05	0.003	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	7.62e-05	0.00297	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	7.59e-05	0.00295	CbGpPWpGaD
Sertraline—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	7.59e-05	0.00295	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	7.43e-05	0.00289	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	7.3e-05	0.00284	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	7.3e-05	0.00284	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.26e-05	0.00283	CbGpPWpGaD
Sertraline—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.2e-05	0.0028	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.16e-05	0.00279	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	7e-05	0.00272	CbGpPWpGaD
Sertraline—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	6.94e-05	0.0027	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	6.88e-05	0.00268	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.62e-05	0.00258	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	6.58e-05	0.00256	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.57e-05	0.00256	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	6.5e-05	0.00253	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	6.47e-05	0.00252	CbGpPWpGaD
Sertraline—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.45e-05	0.00251	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	6.21e-05	0.00242	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.21e-05	0.00242	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	6.11e-05	0.00238	CbGpPWpGaD
Sertraline—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	6.07e-05	0.00236	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.04e-05	0.00235	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.99e-05	0.00233	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.66e-05	0.0022	CbGpPWpGaD
Sertraline—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	5.49e-05	0.00213	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.21e-05	0.00203	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.12e-05	0.00199	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.06e-05	0.00197	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	4.92e-05	0.00191	CbGpPWpGaD
Sertraline—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	4.76e-05	0.00185	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	4.76e-05	0.00185	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.63e-05	0.0018	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.61e-05	0.0018	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.61e-05	0.0018	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.43e-05	0.00172	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.43e-05	0.00172	CbGpPWpGaD
Sertraline—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	4.35e-05	0.00169	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.34e-05	0.00169	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.3e-05	0.00167	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.27e-05	0.00166	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.22e-05	0.00164	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.16e-05	0.00162	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.15e-05	0.00161	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.09e-05	0.00159	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.05e-05	0.00158	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.05e-05	0.00157	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.95e-05	0.00154	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.95e-05	0.00154	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.94e-05	0.00153	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.94e-05	0.00153	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.92e-05	0.00153	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.92e-05	0.00153	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.92e-05	0.00153	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.92e-05	0.00152	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.9e-05	0.00152	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.89e-05	0.00151	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.84e-05	0.00149	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	3.84e-05	0.00149	CbGpPWpGaD
Sertraline—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	3.81e-05	0.00148	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.73e-05	0.00145	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.69e-05	0.00144	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.61e-05	0.0014	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.56e-05	0.00138	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.5e-05	0.00136	CbGpPWpGaD
Sertraline—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	3.44e-05	0.00134	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.41e-05	0.00133	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.35e-05	0.0013	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.35e-05	0.0013	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.23e-05	0.00126	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.19e-05	0.00124	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.15e-05	0.00123	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.15e-05	0.00123	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.01e-05	0.00117	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.98e-05	0.00116	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.98e-05	0.00116	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.94e-05	0.00114	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.9e-05	0.00113	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.77e-05	0.00108	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.74e-05	0.00107	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.73e-05	0.00106	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.71e-05	0.00105	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.69e-05	0.00105	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.68e-05	0.00104	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.67e-05	0.00104	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.64e-05	0.00103	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	2.61e-05	0.00101	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.57e-05	0.001	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.54e-05	0.000989	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.54e-05	0.000987	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.53e-05	0.000984	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.52e-05	0.000981	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.43e-05	0.000944	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	2.41e-05	0.000937	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.38e-05	0.000928	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.29e-05	0.000892	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.29e-05	0.000892	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.26e-05	0.000879	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.25e-05	0.000877	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.25e-05	0.000877	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.2e-05	0.000856	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.2e-05	0.000856	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.18e-05	0.000849	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.16e-05	0.000841	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.16e-05	0.000839	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.1e-05	0.000818	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.07e-05	0.000806	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.07e-05	0.000806	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.06e-05	0.000803	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.06e-05	0.000802	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.06e-05	0.0008	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.06e-05	0.0008	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.01e-05	0.000783	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	1.98e-05	0.000769	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.95e-05	0.000759	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.95e-05	0.000759	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.92e-05	0.000746	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.92e-05	0.000745	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.9e-05	0.000738	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.88e-05	0.000731	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.87e-05	0.000728	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.8e-05	0.000701	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000688	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.76e-05	0.000686	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.76e-05	0.000684	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.76e-05	0.000683	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.76e-05	0.000683	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.75e-05	0.00068	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.74e-05	0.000679	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.74e-05	0.000676	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.69e-05	0.000659	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.66e-05	0.000645	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.65e-05	0.000642	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.64e-05	0.000639	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.64e-05	0.000637	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.63e-05	0.000636	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.63e-05	0.000634	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.61e-05	0.000625	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.59e-05	0.000619	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000605	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.51e-05	0.000587	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.5e-05	0.000583	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.49e-05	0.000581	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.49e-05	0.000578	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.4e-05	0.000546	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.37e-05	0.000532	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.36e-05	0.000527	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.36e-05	0.000527	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000498	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.27e-05	0.000494	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.27e-05	0.000494	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.24e-05	0.000482	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.24e-05	0.000482	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.23e-05	0.00048	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.21e-05	0.000469	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.15e-05	0.000448	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.14e-05	0.000443	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.14e-05	0.000442	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.13e-05	0.000438	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.11e-05	0.000433	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.08e-05	0.000422	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.08e-05	0.000419	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.000413	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.05e-05	0.000408	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.04e-05	0.000404	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000404	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.8e-06	0.000381	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.76e-06	0.00038	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	9.62e-06	0.000374	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.46e-06	0.000368	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.36e-06	0.000364	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.13e-06	0.000355	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.88e-06	0.000345	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.77e-06	0.000341	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.61e-06	0.000335	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.54e-06	0.000332	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.53e-06	0.000332	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.14e-06	0.000317	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.09e-06	0.000315	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	8.03e-06	0.000313	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.79e-06	0.000303	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.43e-06	0.000289	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	7.29e-06	0.000284	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.85e-06	0.000267	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.66e-06	0.000259	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.65e-06	0.000259	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.12e-06	0.000238	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.85e-06	0.000228	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.63e-06	0.000219	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.51e-06	0.000214	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.34e-06	0.000208	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	5.03e-06	0.000196	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.03e-06	0.000196	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.91e-06	0.000191	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.63e-06	0.00018	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.62e-06	0.00018	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.59e-06	0.000178	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.56e-06	0.000177	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.51e-06	0.000176	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.25e-06	0.000165	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.21e-06	0.000164	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.92e-06	0.000152	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.8e-06	0.000148	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.71e-06	0.000144	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.6e-06	0.00014	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.5e-06	0.000136	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.47e-06	0.000135	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.45e-06	0.000134	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.02e-06	0.000118	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.96e-06	0.000115	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.78e-06	0.000108	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.61e-06	0.000101	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.54e-06	9.9e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.4e-06	9.32e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.38e-06	9.24e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.29e-06	8.9e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.03e-06	7.9e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.57e-06	6.1e-05	CbGpPWpGaD
